Serum CA125 and HE4 levels as predictors for optimal interval surgery and platinum sensitivity after neoadjuvant platinum-based chemotherapy in patients with advanced epithelial ovarian cancer

BACKGROUND: The aim of this study is to evaluate a new tumour marker, HE4, and to compare it with CA125 in predicting optimal cytoreduction and response to chemotherapy. Thirty patients with advanced epithelial ovarian cancer and multiple sera harvested during neoadjuvant chemotherapy (NAC) were inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelissier, Aurélie, Roulot, Aurélie, Guéry, Béatrice, Bonneau, Claire, Bellet, Dominique, Rouzier, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039904/
https://www.ncbi.nlm.nih.gov/pubmed/27677313
http://dx.doi.org/10.1186/s13048-016-0270-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039904/
https://www.ncbi.nlm.nih.gov/pubmed/27677313
http://dx.doi.org/10.1186/s13048-016-0270-7

Ejemplares similares